Bioprocessing White Papers

31. The Proven, Practical Gateway To Upstream Process Intensification 11/18/2025

    N-1 perfusion enables higher inoculum densities, faster production, and reduced costs without altering fed-batch processes. Explore a practical path to intensification for biologics manufacturers.

32. Rethinking Peptones As First-Line Optimization Tools 11/14/2025

    Peptones enhance CHO cell growth, viability, and yield, offering a fast, low-risk way to improve bioprocess performance without major process changes.

33. Isolate Bright GFP-Expressing HEK293 Cells For Cell Line Development Workflow 11/7/2025

    Explore a high-efficiency workflow for isolating and expanding GFP-expressing HEK293 cells that enables stable, bright clones ideal for imaging and tracking to simplify clonal development.

34. Generate CHO-K1 GFP-Expressing Cells For Cell Line Development Workflow 11/7/2025

    Discover a high-efficiency workflow for generating GFP-expressing CHO-K1 clones using automated single-cell dispensing to achieve 93% isolation success and stable expression in under five weeks.

35. Build An AAV8 Platform: Lessons From A Collaborative Development Journey 11/5/2025

    Explore how a modular AAV8 platform enables scalable, GMP-ready gene therapy manufacturing with reproducible outcomes, streamlined tech transfer, and adaptability across serotypes.

36. Excellence In Peptide And Oligonucleotide Purification 11/5/2025

    Explore how digital tools are advancing peptide purification, with a focus on GLP-1 receptor agonists, as well as how process efficiency can be accelerated through real-time insights.

37. Tools For Efficient And Reliable Gene Therapy Manufacturing 11/5/2025

    Discover scalable strategies for overcoming AAV purification challenges, from low yield and impurity removal to serotype variability, as well as how advanced tools can streamline manufacturing.

38. Enabling The Future Of Intensified Biomanufacturing 11/5/2025

    Process intensification demands smarter orchestration, real-time analytics, and scalable automation. Discover how digital infrastructure enables synchronized, compliant, and predictive biomanufacturing.

39. Unlocking ROI And Capacity In Monoclonal Antibody Manufacturing 11/5/2025

    Perfusion-based upstream production offers up to 24% lower cost and significantly higher productivity than fed-batch, enabling faster timelines, better facility utilization, and improved quality.

40. Leveraging 3 Distinct Resins To Provide Effective Impurity Removal For mAbs And Novel Antibody Derivatives 11/3/2025

    Due to the complexity of bispecifics, Fc-fusion proteins, and Fab fragments, their manufacturing poses added purification challenges and requires a robust toolkit of purification techniques.